BCR and lymphoma: In addition, given the similarities with CLL and the finding that MCL cells frequently present neoantigenic peptides derived from the lymphoma immunoglobulin heavy- or light-chain variable regions to idiotype-specific T cells [135], it remains possible that the BCR pathway is activated in a subset of cases by cell-autonomous BCR interactions.